C07D 407/04
Directly linked by a ring-member-to-ring-member bond
Official title: directly linked by a ring-member-to-ring-member bond
C07D407/04 (Directly linked by a ring-member-to-ring-member bond) appears on 655 US grants and 696 published applications in this corpus.
Search patents in C07D- Granted patents
- 655
- Published applications
- 696
- Assignees
- 463
- Inventors
- 2,756
- Latest grant
- 7 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 6 | 0 |
| 1978 | 3 | 0 |
| 1979 | 2 | 0 |
| 1980 | 0 | 0 |
| 1981 | 3 | 0 |
| 1982 | 3 | 0 |
| 1983 | 1 | 0 |
| 1984 | 3 | 0 |
| 1985 | 11 | 0 |
| 1986 | 6 | 0 |
| 1987 | 7 | 0 |
| 1988 | 8 | 0 |
| 1989 | 6 | 0 |
| 1990 | 8 | 0 |
| 1991 | 17 | 0 |
| 1992 | 14 | 0 |
| 1993 | 7 | 0 |
| 1994 | 5 | 0 |
| 1995 | 11 | 0 |
| 1996 | 20 | 0 |
| 1997 | 21 | 0 |
| 1998 | 6 | 0 |
| 1999 | 7 | 0 |
| 2000 | 18 | 0 |
| 2001 | 12 | 4 |
| 2002 | 12 | 12 |
| 2003 | 10 | 19 |
| 2004 | 9 | 23 |
| 2005 | 9 | 18 |
| 2006 | 11 | 18 |
| 2007 | 7 | 14 |
| 2008 | 7 | 16 |
| 2009 | 17 | 24 |
| 2010 | 12 | 33 |
| 2011 | 8 | 29 |
| 2012 | 23 | 39 |
| 2013 | 31 | 37 |
| 2014 | 30 | 35 |
| 2015 | 28 | 41 |
| 2016 | 37 | 38 |
| 2017 | 25 | 25 |
| 2018 | 19 | 34 |
| 2019 | 23 | 33 |
| 2020 | 36 | 30 |
| 2021 | 19 | 33 |
| 2022 | 17 | 20 |
| 2023 | 21 | 33 |
| 2024 | 16 | 32 |
| 2025 | 19 | 28 |
| 2026 | 2 | 28 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Aromatic compounds for organic electroluminescent devices7 Apr 2026US 12,595,271 B2UDC Ireland Limited
- Prostaglandin E2 (PGE2) EP4 receptor antagonists20 Jan 2026US 12,527,779 B2Domain Therapeutics
- Heterocyclic compound, organic light emitting device comprising the same, method for manufacturing the same and composition for organic material layer of organic light emitting device30 Dec 2025US 12,514,118 B2Lt Materials Co., Ltd.
- Compounds for the treatment of kinase-dependent disorders23 Dec 2025US 12,503,438 B2Exelixis, Inc.
- Intermediate useful for synthesis of SGLT inhibitor and method for preparing SGLT inhibitor using same16 Dec 2025US 12,497,390 B2Daewoong Pharmaceutical Co., Ltd.
- Matrix metalloproteinase (mmp) inhibitors and methods of use thereof10 Sep 2026US 2026/0265232 A1Foresee Pharmaceuticals USA, Inc.
- At2 antagonists for non-addictive pain relief20 Aug 2026US 2026/0242357 A1Board of Regents, The University of Texas System
- Benzopyrone compounds as well as preparation method therefor and use thereof16 Jul 2026US 2026/0200885 A1Chengdu Di’ao Jiuhong Pharmaceutical Factory
- Pharmaceutical composition for ameliorating malignant diseases16 Jul 2026US 2026/0200903 A1Kinki University
- Aromatic compounds for organic electroluminescent devices16 Jul 2026US 2026/0200952 A1UDC Ireland Limited
Most cited
By later US patents
- Photochromic indeno-fused naphthopyrans245US 5,645,767 ATransitions Optical, Inc. · 1997
- Photochromic naphthopyran compounds182US 5,384,077 ATransitions Optical, Inc. · 1995
- Substituted naphthopyrans153US 5,458,814 ATransitions Optical, Inc. · 1995
- Heteroaryl sulfonamides and CCR292US 7,622,583 B2ChemoCentryx, Inc. · 2009
- Benzopyrans and use thereof in treating vascular diseases84US 4,814,346 AZyma SA · 1989